FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4280490316> ?p ?o ?g. }

• W4280490316 endingPage "100112" @default.
• W4280490316 startingPage "100112" @default.
• W4280490316 abstract "BackgroundIn-hospital outcomes for percutaneous coronary interventions (PCI) and mechanical circulatory support (MCS) in patients with end-stage renal disease (ESRD) presented with the acute coronary syndrome (ACS) are unknown.MethodsUsing the NIS database, patients with ACS who received PCI and MCS, including those with ESRD, were included in the study. The odds ratio was calculated to compare in-hospital outcomes between patients with ESRD versus no ESRD.ResultsWe identified a total of 9,614,249 patients (9,343,527 without ESRD; 270,722 with ESRD). The patients with ESRD had increased diabetes, valvular abnormalities, heart failure, and electrolyte abnormalities. The odds of stroke (4.3% vs 2.7%, OR: 1.6; 95% CI 1.52-1.71), major bleeding (14.2% vs 12.7%, OR: 1.14; 95% CI 1.10-1.17), and in-hospital mortality (40.2% vs 21.6%, OR: 2.44; 95% CI 2.38-2.50), P<.0001 for all, were significantly higher in patients with ESRD compared to those without ESRD. The odds of vascular complications were also significantly decreased (2.3% vs 2.6%, OR: 0.90; 95% CI 0.83-0.97), P=.005.ConclusionsDisclosuresA. Chalek Nothing to disclose. C. Dandu Nothing to disclose. M. Zghouzi Nothing to disclose. W. Ullah Nothing to disclose. P. Razvi Nothing to disclose. H. Osman Nothing to disclose. A. R. M. Suleiman Nothing to disclose. Y. Sattar Nothing to disclose. C. Oviedo Nothing to disclose. N. Elmakshbr Nothing to disclose. R. Alhusain Nothing to disclose. N. M. Lakkis Nothing to disclose. M. C. Alraies Nothing to disclose. BackgroundIn-hospital outcomes for percutaneous coronary interventions (PCI) and mechanical circulatory support (MCS) in patients with end-stage renal disease (ESRD) presented with the acute coronary syndrome (ACS) are unknown. In-hospital outcomes for percutaneous coronary interventions (PCI) and mechanical circulatory support (MCS) in patients with end-stage renal disease (ESRD) presented with the acute coronary syndrome (ACS) are unknown. MethodsUsing the NIS database, patients with ACS who received PCI and MCS, including those with ESRD, were included in the study. The odds ratio was calculated to compare in-hospital outcomes between patients with ESRD versus no ESRD. Using the NIS database, patients with ACS who received PCI and MCS, including those with ESRD, were included in the study. The odds ratio was calculated to compare in-hospital outcomes between patients with ESRD versus no ESRD. ResultsWe identified a total of 9,614,249 patients (9,343,527 without ESRD; 270,722 with ESRD). The patients with ESRD had increased diabetes, valvular abnormalities, heart failure, and electrolyte abnormalities. The odds of stroke (4.3% vs 2.7%, OR: 1.6; 95% CI 1.52-1.71), major bleeding (14.2% vs 12.7%, OR: 1.14; 95% CI 1.10-1.17), and in-hospital mortality (40.2% vs 21.6%, OR: 2.44; 95% CI 2.38-2.50), P<.0001 for all, were significantly higher in patients with ESRD compared to those without ESRD. The odds of vascular complications were also significantly decreased (2.3% vs 2.6%, OR: 0.90; 95% CI 0.83-0.97), P=.005. We identified a total of 9,614,249 patients (9,343,527 without ESRD; 270,722 with ESRD). The patients with ESRD had increased diabetes, valvular abnormalities, heart failure, and electrolyte abnormalities. The odds of stroke (4.3% vs 2.7%, OR: 1.6; 95% CI 1.52-1.71), major bleeding (14.2% vs 12.7%, OR: 1.14; 95% CI 1.10-1.17), and in-hospital mortality (40.2% vs 21.6%, OR: 2.44; 95% CI 2.38-2.50), P<.0001 for all, were significantly higher in patients with ESRD compared to those without ESRD. The odds of vascular complications were also significantly decreased (2.3% vs 2.6%, OR: 0.90; 95% CI 0.83-0.97), P=.005. Conclusions DisclosuresA. Chalek Nothing to disclose. C. Dandu Nothing to disclose. M. Zghouzi Nothing to disclose. W. Ullah Nothing to disclose. P. Razvi Nothing to disclose. H. Osman Nothing to disclose. A. R. M. Suleiman Nothing to disclose. Y. Sattar Nothing to disclose. C. Oviedo Nothing to disclose. N. Elmakshbr Nothing to disclose. R. Alhusain Nothing to disclose. N. M. Lakkis Nothing to disclose. M. C. Alraies Nothing to disclose. A. Chalek Nothing to disclose. C. Dandu Nothing to disclose. M. Zghouzi Nothing to disclose. W. Ullah Nothing to disclose. P. Razvi Nothing to disclose. H. Osman Nothing to disclose. A. R. M. Suleiman Nothing to disclose. Y. Sattar Nothing to disclose. C. Oviedo Nothing to disclose. N. Elmakshbr Nothing to disclose. R. Alhusain Nothing to disclose. N. M. Lakkis Nothing to disclose. M. C. Alraies Nothing to disclose." @default.
• W4280490316 created "2022-05-22" @default.
• W4280490316 creator A5005462263 @default.
• W4280490316 creator A5006491306 @default.
• W4280490316 creator A5011394495 @default.
• W4280490316 creator A5012870903 @default.
• W4280490316 creator A5013992970 @default.
• W4280490316 creator A5034094942 @default.
• W4280490316 creator A5034903228 @default.
• W4280490316 creator A5050809751 @default.
• W4280490316 creator A5055248313 @default.
• W4280490316 creator A5056742736 @default.
• W4280490316 creator A5062124493 @default.
• W4280490316 creator A5078812233 @default.
• W4280490316 creator A5087694600 @default.
• W4280490316 date "2022-05-01" @default.
• W4280490316 modified "2023-09-26" @default.
• W4280490316 title "B-5 | In-Hospital Outcomes for Patients with End-Stage Renal Disease and Acute Coronary Syndrome Treated with Percutaneous Coronary Intervention with Mechanical Circulatory Support" @default.
• W4280490316 doi "https://doi.org/10.1016/j.jscai.2022.100112" @default.
• W4280490316 hasPublicationYear "2022" @default.
• W4280490316 type Work @default.
• W4280490316 citedByCount "0" @default.
• W4280490316 crossrefType "journal-article" @default.
• W4280490316 hasAuthorship W4280490316A5005462263 @default.
• W4280490316 hasAuthorship W4280490316A5006491306 @default.
• W4280490316 hasAuthorship W4280490316A5011394495 @default.
• W4280490316 hasAuthorship W4280490316A5012870903 @default.
• W4280490316 hasAuthorship W4280490316A5013992970 @default.
• W4280490316 hasAuthorship W4280490316A5034094942 @default.
• W4280490316 hasAuthorship W4280490316A5034903228 @default.
• W4280490316 hasAuthorship W4280490316A5050809751 @default.
• W4280490316 hasAuthorship W4280490316A5055248313 @default.
• W4280490316 hasAuthorship W4280490316A5056742736 @default.
• W4280490316 hasAuthorship W4280490316A5062124493 @default.
• W4280490316 hasAuthorship W4280490316A5078812233 @default.
• W4280490316 hasAuthorship W4280490316A5087694600 @default.
• W4280490316 hasBestOaLocation W42804903161 @default.
• W4280490316 hasConcept C111472728 @default.
• W4280490316 hasConcept C126322002 @default.
• W4280490316 hasConcept C136815107 @default.
• W4280490316 hasConcept C138885662 @default.
• W4280490316 hasConcept C156957248 @default.
• W4280490316 hasConcept C164705383 @default.
• W4280490316 hasConcept C2777698277 @default.
• W4280490316 hasConcept C2779134260 @default.
• W4280490316 hasConcept C2780400711 @default.
• W4280490316 hasConcept C3019040382 @default.
• W4280490316 hasConcept C45393284 @default.
• W4280490316 hasConcept C500558357 @default.
• W4280490316 hasConcept C71924100 @default.
• W4280490316 hasConceptScore W4280490316C111472728 @default.
• W4280490316 hasConceptScore W4280490316C126322002 @default.
• W4280490316 hasConceptScore W4280490316C136815107 @default.
• W4280490316 hasConceptScore W4280490316C138885662 @default.
• W4280490316 hasConceptScore W4280490316C156957248 @default.
• W4280490316 hasConceptScore W4280490316C164705383 @default.
• W4280490316 hasConceptScore W4280490316C2777698277 @default.
• W4280490316 hasConceptScore W4280490316C2779134260 @default.
• W4280490316 hasConceptScore W4280490316C2780400711 @default.
• W4280490316 hasConceptScore W4280490316C3019040382 @default.
• W4280490316 hasConceptScore W4280490316C45393284 @default.
• W4280490316 hasConceptScore W4280490316C500558357 @default.
• W4280490316 hasConceptScore W4280490316C71924100 @default.
• W4280490316 hasIssue "3" @default.
• W4280490316 hasLocation W42804903161 @default.
• W4280490316 hasOpenAccess W4280490316 @default.
• W4280490316 hasPrimaryLocation W42804903161 @default.
• W4280490316 hasRelatedWork W193640619 @default.
• W4280490316 hasRelatedWork W2127687375 @default.
• W4280490316 hasRelatedWork W2355614377 @default.
• W4280490316 hasRelatedWork W2375576842 @default.
• W4280490316 hasRelatedWork W2375584960 @default.
• W4280490316 hasRelatedWork W2378890344 @default.
• W4280490316 hasRelatedWork W2782203991 @default.
• W4280490316 hasRelatedWork W3029377117 @default.
• W4280490316 hasRelatedWork W3029448752 @default.
• W4280490316 hasRelatedWork W4318064246 @default.
• W4280490316 hasVolume "1" @default.
• W4280490316 isParatext "false" @default.
• W4280490316 isRetracted "false" @default.
• W4280490316 workType "article" @default.